We have located links that may give you full text access.
Stable Iodine Distribution among Children after the 2011 Fukushima Nuclear Disaster in Japan: An Observational Study.
Journal of Clinical Endocrinology and Metabolism 2018 December 11
Context: Intake of stable iodine helps prevent childhood thyroid cancer in nuclear emergencies but there is limited case information.
Objective: We identified the intake rate and the factors associated with no intake among children who did not take stable iodine after the Fukushima disaster.
Design: Retrospective observational study.
Setting: Data were obtained from thyroid cancer screening performed in August-November 2017.
Participants: Children in Miharu Town, Fukushima, Japan.
Intervention: No intervention.
Main Outcome Measures: We performed multilevel logistic regression analysis at the regional and individual levels. We qualitatively examined the reasons for no intake of stable iodine based on closed- and open-ended questions.
Results: The rate of distribution was 94.9%, but the intake rate was only 63.5%. Intake was lower in those aged 0-2 years compared with those aged ≥3 years: odds ratio (OR), 0.21 [95% confidence interval (CI), 0.11-0.36]. Parents' intake was positively associated with their children's intake [OR, 61.0 (95% CI, 37.9-102.9)]. The variance partition coefficient for regions was 0.021, suggesting that the intake of stable iodine was more likely affected by individual than by regional factors. The main reasons for avoiding intake were concern about safety, issues related to distribution, drug information sharing, and instructions for intake. There were no claimed adverse effects.
Conclusions: The distribution and consumption of stable iodine occurred without claims of adverse effects after the Fukushima disaster. To prepare for future nuclear emergencies, it is important to explain to both children and parents the need for intake of stable iodine, particularly among young children.
Objective: We identified the intake rate and the factors associated with no intake among children who did not take stable iodine after the Fukushima disaster.
Design: Retrospective observational study.
Setting: Data were obtained from thyroid cancer screening performed in August-November 2017.
Participants: Children in Miharu Town, Fukushima, Japan.
Intervention: No intervention.
Main Outcome Measures: We performed multilevel logistic regression analysis at the regional and individual levels. We qualitatively examined the reasons for no intake of stable iodine based on closed- and open-ended questions.
Results: The rate of distribution was 94.9%, but the intake rate was only 63.5%. Intake was lower in those aged 0-2 years compared with those aged ≥3 years: odds ratio (OR), 0.21 [95% confidence interval (CI), 0.11-0.36]. Parents' intake was positively associated with their children's intake [OR, 61.0 (95% CI, 37.9-102.9)]. The variance partition coefficient for regions was 0.021, suggesting that the intake of stable iodine was more likely affected by individual than by regional factors. The main reasons for avoiding intake were concern about safety, issues related to distribution, drug information sharing, and instructions for intake. There were no claimed adverse effects.
Conclusions: The distribution and consumption of stable iodine occurred without claims of adverse effects after the Fukushima disaster. To prepare for future nuclear emergencies, it is important to explain to both children and parents the need for intake of stable iodine, particularly among young children.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app